Press Releases

HANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In line with the firm's corporate mission of delivering a "Beautiful and Better Life", Proya Cosmetics Co., Ltd. (SHA: 603605) is contributing to the effort to control and prevent further expansion of the 2019 novel Coronavirus (2019-nCoV) epidemic during these critical days.

PALM DESERT, Calif., Jan. 29, 2020 /PRNewswire/ -- PBS's longest-running national series, Windsor Broadcasting's American Health Journal, announced new agreements w

ATLANTA, Jan. 29, 2020 /PRNewswire/ -- Craneware (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today announced an upcoming series of webinars that

GUANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In the last few days, all attention in China is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Medical staff from both Wuhan and around the country, as well as people from all walks of life, are working together to win the

YOKNEAM, Israel, Jan. 29, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, will participate in the IMCAS World Congress, one of the largest European meetings of plastic and aesthetic surgeons, which will take place in Paris, France from

SAN DIEGO, Jan. 29, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developmen

SAN DIEGO, Jan. 29, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, colorectal and leukemia, announced today that it has received approximately

BOSTON, Jan. 29, 2020 /PRNewswire/ -- Based on the company's continued growth and success, as well as an increasing demand for its services, CCRM (Colorado Center for Reproductive Medicine) Fertility, a

LOS ANGELES, Jan. 29, 2020 /PRNewswire/ -- Hawkeye Systems, Inc. (OTCQB:  

MORRISTOWN, N.J., Jan. 29, 2020 /PRNewswire/ -- Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) injection 100 mg/mL.  Monoferric® is an intravenous iron indicated for the treatment of iron deficiency anemia (IDA) in adult patients who have an intolerance to